An outbreak of Serratia marcescens septicemia in neonates.
Serratia marcescens is a well recognized nosocomial pathogen. We report an outbreak with this organism in 8 neonates in a neonatal intensive care unit (NICU). Seven cases were treated successfully with meropenem after the failure of imipenem treatment. Although they have similar anti-microbial effects, meropenem can effectively treat the S. marcescens sepsis resistant to imipenem.
Guler
Ekrem
E
Department of Pediatric, Kahramanmaras Sutcu Imam University, Kahramanmaras 46050, Turkey. ekremguler@hotmail.com
Davutoglu
Mehmet
M
Ucmak
Hasan
H
Karabiber
Hamza
H
Kokoglu
Omer Faruk
OF
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology*; D004196:Disease Outbreaks; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D000077731:Meropenem; D016868:Serratia Infections / Q000453:epidemiology*; D012706:Serratia marcescens; D013845:Thienamycins / Q000627:therapeutic use; D014421:Turkey / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem